N-(2-methylbutan-2-yl)-2-[3-[4-(4-pyrazolidin-4-ylanilino)thieno[3,2-d]pyrimidin-2-yl]phenoxy]acetamide
C28H32N6O2S — CID 155883620
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-methylbutan-2-yl)-2-[3-[4-(4-pyrazolidin-4-ylanilino)thieno[3,2-d]pyrimidin-2-yl]phenoxy]acetamide
N-(2-methylbutan-2-yl)-2-[3-[4-(4-pyrazolidin-4-ylanilino)thieno[3,2-d]pyrimidin-2-yl]phenoxy]acetamide (PubChem CID 155883620) has the molecular formula C28H32N6O2S and a molecular weight of 516.67 g/mol. Its IUPAC name is N-(2-methylbutan-2-yl)-2-[3-[4-(4-pyrazolidin-4-ylanilino)thieno[3,2-d]pyrimidin-2-yl]phenoxy]acetamide.
Molecular Properties
| Compound Name | N-(2-methylbutan-2-yl)-2-[3-[4-(4-pyrazolidin-4-ylanilino)thieno[3,2-d]pyrimidin-2-yl]phenoxy]acetamide |
|---|---|
| PubChem CID | 155883620 |
| Molecular Formula | C28H32N6O2S |
| Molecular Weight | 516.67 g/mol |
| Exact Mass | 516.23 |
| IUPAC Name | N-(2-methylbutan-2-yl)-2-[3-[4-(4-pyrazolidin-4-ylanilino)thieno[3,2-d]pyrimidin-2-yl]phenoxy]acetamide |
| SMILES | CCC(C)(C)NC(=O)COc1cccc(-c2nc(Nc3ccc(C4CNNC4)cc3)c3sccc3n2)c1 |
| InChI | InChI=1S/C28H32N6O2S/c1-4-28(2,3)34-24(35)17-36-22-7-5-6-19(14-22)26-32-23-12-13-37-25(23)27(33-26)31-21-10-8-18(9-11-21)20-15-29-30-16-20/h5-14,20,29-30H,4,15-17H2,1-3H3,(H,34,35)(H,31,32,33) |
| InChIKey | DKMIAOZBZWJVIP-UHFFFAOYSA-N |
| XLogP | 4.98 |
| TPSA | 100.20 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 516.67 |
| LogP ≤ 5 | 4.98 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155883620 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.